Bristol Feels Plavix And Pravachol Pain; Does Relief Lie In Conservative R&D?

As Bristol-Myers Squibb prepares to weather patent losses for its two top-selling products - Pravachol and Plavix - the firm is sticking by a conservative approach to research & development